Third Point Sets Sights On Nabi, Again

Nov 2 2006 | 11:54am ET

If there’s one thing we’ve learned about Daniel Loeb of Third Point, it’s that he makes good on his threats.

The activist hedge fund manager has filed a proxy statement seeking to boot five members–a majority–of the board of Nabi Biopharmaceuticals, including its CEO, Thomas McLain. Third Point owns 8.4% of the Boca Raton, Fla.-based company.


In Depth

Q&A: Ovid Capital Bets On Banks’ Need For Regulatory Capital Relief

May 21 2012 | 9:59am ET

The Basel III Accords, regulations covering banks which will take effect in Europe...

Lifestyle

Oaktree Founder Pays $52.5 Million For Manhattan Co-Op, A Record

May 15 2012 | 12:16pm ET

A co-founder of Los Angeles-based Oaktree Capital Management has paid a record amount...

Guest Contributor

Non-Agency Mortgages Offer Compelling Value

May 21 2012 | 8:33am ET

The non-agency mortgage market remains dislocated and is one segment of the fixed...

 

Upcoming Events

Most Popular

Service Providers


Publisher's Note

    Save The Date: FINforums Annual Hedge Fund Summit

    Mar 2 2012 | 4:10am ET

    Deirdre BrennanDeirdre BrennanFINforums, the events arm of FINalternatives, is holding its Annual Hedge Fund Summit on Sept. 20, 2012 at the Sentry Centers in New York City. Don't miss out on this chance to meet and mingle with the top decision makers and investors in the alternative asset management industry. Read more…